Reports for METHYLPHENIDATE HYDROCHLORIDE

Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
FOQUEST 35MG CAPSULE (CONTROLLED RELEASE) Resolved 2021-12-02 2021-12-23 150348
FOQUEST 35MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-04-15 2022-04-29 158913
FOQUEST 35MG CAPSULE (CONTROLLED RELEASE) Avoided shortage 2023-02-03 2023-02-16 183530
FOQUEST 35MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-06-20 2023-06-24 195939
FOQUEST 35MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-08-08 2023-08-18 201413
FOQUEST 25MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-04-15 2022-04-23 158910
FOQUEST 25MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-08-11 2022-08-18 166500
FOQUEST 25MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-10-07 2022-10-22 171389
FOQUEST 25MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-12-09 2022-12-15 177645
FOQUEST 25MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-04-28 2023-05-03 191152

Showing 161 to 170 of 194

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
METHYLPHENIDATE 5MG TABLET Discontinued 2019-04-10 2019-04-11 81132
METHYLPHENIDATE 10MG TABLET Discontinued 2019-04-10 2019-04-11 81136
METHYLPHENIDATE 20MG TABLET Discontinued 2019-04-10 2019-04-11 81139
PMS-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118105
PMS-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118099
PMS-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118108
PMS-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118102
RITALIN 10MG 10MG TABLET Discontinued 2022-02-08 2022-05-11 154449
RITALIN 20MG 20MG TABLET Discontinued 2019-07-22 2019-08-01 89771
RITALIN-SR TAB 20MG 20MG TABLET (EXTENDED-RELEASE) Discontinued 2022-02-08 2022-04-05 154439

Showing 1 to 10 of 11